Harmony Gross Profit from 2010 to 2024

HRMY Stock

USD 34.67 1.08 3.02%

Harmony Biosciences Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit is likely to outpace its year average in 2024. Gross Profit is the profit Harmony Biosciences Holdings makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2019-06-30

Previous Quarter

134.7 M

Current Value

143.3 M

Quarterly Volatility

45.4 M

Covid

Check Harmony Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harmony Biosciences' main balance sheet or income statement drivers, such as Tax Provision of 28.4 M, Depreciation And Amortization of 14.7 M or Interest Expense of 17.9 M, as well as many indicators such as Price To Sales Ratio of 3.14, Dividend Yield of 0.0 or PTB Ratio of 4.32. Harmony financial statements analysis is a perfect complement when working with Harmony Biosciences Valuation or Volatility modules.

Check out the analysis of Harmony Biosciences Correlation against competitors.

Latest Harmony Biosciences' Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Harmony Biosciences Holdings over the last few years. Gross profit is a required income statement account that reflects total revenue of Harmony Biosciences Holdings minus its cost of goods sold. It is profit before Harmony Biosciences operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Harmony Biosciences' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Harmony Biosciences' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 354.37 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Harmony Gross Profit Regression Statistics

	Arithmetic Mean	112,355,287
	Geometric Mean	0.00
	Coefficient Of Variation	161.78
	Mean Deviation	149,217,982
	Median	0.00
	Standard Deviation	181,765,452
	Sample Variance	33038.7T
	Range	483.8M
	R-Value	0.82
	Mean Square Error	11676.4T
	R-Squared	0.67
	Significance	0.0002
	Slope	33,313,925
	Total Sum of Squares	462541.5T

Harmony Gross Profit History

	2024	483.8 M
	2023	460.8 M
	2022	354.4 M
	2021	249.9 M
	2020	132 M
	2019	4.4 M

Other Fundumenentals of Harmony Biosciences

Gross Profit Margin

Harmony Biosciences Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Common Stock	Property Plant Equipment	Long Term Debt	Intangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Current Deferred Revenue	Short Long Term Debt	Short Term Debt
Total Assets		0.87	0.91	-0.12	0.02	0.66	0.93	0.95	0.99	-0.92	0.94	-0.51	-0.98	0.91	0.9	-0.61	0.9	-0.51	0.88	0.63	0.63
Total Stockholder Equity	0.87		0.96	-0.41	0.42	0.8	0.71	0.92	0.87	-0.8	0.88	-0.78	-0.83	0.76	0.74	-0.85	0.93	-0.78	0.91	0.82	0.82
Net Tangible Assets	0.91	0.96		-0.42	0.26	0.67	0.79	0.96	0.94	-0.92	0.94	-0.68	-0.87	0.87	0.86	-0.76	0.88	-0.68	0.84	0.71	0.71
Net Debt	-0.12	-0.41	-0.42		-0.77	-0.21	0.13	-0.19	-0.2	0.16	-0.26	0.38	-0.04	-0.01	0.0	0.37	-0.3	0.38	-0.27	-0.41	-0.41
Retained Earnings	0.02	0.42	0.26	-0.77		0.41	-0.28	0.04	0.04	0.14	0.11	-0.48	0.13	-0.25	-0.26	-0.45	0.36	-0.48	0.42	0.51	0.51
Accounts Payable	0.66	0.8	0.67	-0.21	0.41		0.61	0.7	0.6	-0.53	0.5	-0.92	-0.64	0.52	0.49	-0.93	0.84	-0.92	0.75	0.97	0.97
Total Liab	0.93	0.71	0.79	0.13	-0.28	0.61		0.91	0.9	-0.92	0.79	-0.47	-0.97	0.95	0.95	-0.55	0.75	-0.47	0.69	0.55	0.55
Net Invested Capital	0.95	0.92	0.96	-0.19	0.04	0.7	0.91		0.96	-0.97	0.92	-0.66	-0.96	0.95	0.94	-0.75	0.87	-0.66	0.81	0.7	0.7
Total Current Assets	0.99	0.87	0.94	-0.2	0.04	0.6	0.9	0.96		-0.94	0.96	-0.49	-0.96	0.91	0.91	-0.59	0.88	-0.49	0.86	0.6	0.6
Capital Stock	-0.92	-0.8	-0.92	0.16	0.14	-0.53	-0.92	-0.97	-0.94		-0.89	0.52	0.93	-0.99	-0.98	0.61	-0.75	0.52	-0.67	-0.55	-0.55
Net Working Capital	0.94	0.88	0.94	-0.26	0.11	0.5	0.79	0.92	0.96	-0.89		-0.42	-0.91	0.85	0.84	-0.54	0.85	-0.42	0.85	0.51	0.51
Common Stock	-0.51	-0.78	-0.68	0.38	-0.48	-0.92	-0.47	-0.66	-0.49	0.52	-0.42		0.51	-0.49	-0.46	0.99	-0.72	1.0	-0.59	-0.95	-0.95
Property Plant Equipment	-0.98	-0.83	-0.87	-0.04	0.13	-0.64	-0.97	-0.96	-0.96	0.93	-0.91	0.51		-0.95	-0.94	0.61	-0.85	0.51	-0.81	-0.59	-0.59
Long Term Debt	0.91	0.76	0.87	-0.01	-0.25	0.52	0.95	0.95	0.91	-0.99	0.85	-0.49	-0.95		0.99	-0.58	0.71	-0.49	0.63	0.51	0.51
Intangible Assets	0.9	0.74	0.86	0.0	-0.26	0.49	0.95	0.94	0.91	-0.98	0.84	-0.46	-0.94	0.99		-0.55	0.68	-0.46	0.63	0.47	0.47
Long Term Debt Total	-0.61	-0.85	-0.76	0.37	-0.45	-0.93	-0.55	-0.75	-0.59	0.61	-0.54	0.99	0.61	-0.58	-0.55		-0.8	0.99	-0.67	-0.96	-0.96
Capital Surpluse	0.9	0.93	0.88	-0.3	0.36	0.84	0.75	0.87	0.88	-0.75	0.85	-0.72	-0.85	0.71	0.68	-0.8		-0.72	0.93	0.85	0.85
Deferred Long Term Liab	-0.51	-0.78	-0.68	0.38	-0.48	-0.92	-0.47	-0.66	-0.49	0.52	-0.42	1.0	0.51	-0.49	-0.46	0.99	-0.72		-0.59	-0.95	-0.95
Current Deferred Revenue	0.88	0.91	0.84	-0.27	0.42	0.75	0.69	0.81	0.86	-0.67	0.85	-0.59	-0.81	0.63	0.63	-0.67	0.93	-0.59		0.72	0.72
Short Long Term Debt	0.63	0.82	0.71	-0.41	0.51	0.97	0.55	0.7	0.6	-0.55	0.51	-0.95	-0.59	0.51	0.47	-0.96	0.85	-0.95	0.72		1.0
Short Term Debt	0.63	0.82	0.71	-0.41	0.51	0.97	0.55	0.7	0.6	-0.55	0.51	-0.95	-0.59	0.51	0.47	-0.96	0.85	-0.95	0.72	1.0

Click cells to compare fundamentals

About Harmony Biosciences Financial Statements

Harmony Biosciences investors use historical fundamental indicators, such as Harmony Biosciences' Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Harmony Biosciences. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Gross Profit	460.8 M	483.8 M
Gross Profit Margin	0.79	0.64

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Harmony Stock Analysis

When running Harmony Biosciences' price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC